Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC...
Presence of particulate matter: a white thread-like structure in the cartridge
Quick Facts at a Glance
- Recall Date
- April 24, 2026
- Hazard Level
- HIGH
- Brands
- LIRAGLUTIDE, Lupin Pharmaceuticals, Inc.
- Geographic Scope
- 1 states
Hazard Information
Presence of particulate matter: a white thread-like structure in the cartridge
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Lupin Pharmaceuticals Inc. or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for LIRAGLUTIDE recalls
Be the first to know. Free instant alerts to your inbox.
Full Description
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.. Generic: LIRAGLUTIDE; Brand: LIRAGLUTIDE. Reason: Presence of particulate matter: a white thread-like structure in the cartridge. Classification: Class II. Quantity: 217,621 pen injectors. Distribution: Nationwide within U.S
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: How to Get Refunds and ReplacementsWant to Know First?
Get instant alerts for recalls that affect you. Free forever.